Geotrichum klebahnii: Introduction, Morphology, Pathogenicity, Lab Diagnosis, Treatment, and Prevention
Lacking blastoconidia (budding yeast cells), distinguishing Geotrichum klebahnii from Trichosporon
Introduction
Table of Contents
Geotrichum klebahnii is a rare, opportunistic, yeast-like fungus that is found globally in environments like soil, dairy products, and organic waste, but can act as an emerging pathogen in humans. Along with Geotrichum candidum, it is one of the only species within its genus documented to cause human infection (geotrichosis), particularly targeting immunocompromised or severely traumatized individuals.
Morphology
Macroscopic (Culture): Fast-growing, flat, moist, white-to-cream-colored colonies with a yeast-like or finely filamentous, velvety texture on standard fungal media.
Microscopic: Characterized by true, septate hyphae that fragment by holoarthric division into chains of smooth, single-celled, rectangular or cylindrical arthroconidia.
Fig. Geotrichum klebahnii in LPCB tease mount of culture showing hyphae that fragment by holoarthric division into chains of smooth, single-celled, rectangular or cylindrical arthroconidia
Distinguishing Feature: It lacks blastoconidia (budding yeast cells), distinguishing it from Trichosporon. It also lacks “disjunctor cells” between arthroconidia, distinguishing it from the highly hazardous dimorphic pathogen Coccidioides.
While G. klebahnii has low baseline virulence, it is a highly opportunistic pathogen that causes localized or deep invasive geotrichosis.
Risk Factors: Primarily affects individuals with uncontrolled diabetes mellitus, prolonged neutropenia, HIV/AIDS, hematological malignancies, or those undergoing broad-spectrum antibiotic therapy.
Infection Routes: Can establish infection via traumatic inoculation (burns, wounds, surgery) in healthy individuals, or through systemic dissemination from gut colonization in the vulnerable.
Clinical Presentation: Manifests as deep cutaneous or subcutaneous lesions (e.g., facial or tissue swelling invading salivary glands and bone), bronchial/pulmonary infections, or highly fatal fungemia (bloodstream infection).
Laboratory Diagnosis
Specimen Collection: Biopsy tissue, blood cultures, sputum, or wound scrapings based on clinical signs.
Direct Microscopy: Potassium hydroxide (KOH) wet mounts or histopathological staining (Gomori methenamine silver/PAS) reveal invading hyphae fragmenting into rectangular arthroconidia within tissue samples.
Fungal Culture: Inoculation onto Sabouraud Dextrose Agar (SDA) yields rapid growth of characteristic white, powdery-to-waxy colonies.
Advanced Identification: Standard biochemical profiling can be unreliable. Definitive identification relies on MALDI-TOF mass spectrometry or molecular sequencing (DNA/Next-Gen sequencing).
Treatment
Effective treatment requires managing the patient’s underlying risk factors (e.g., blood sugar control) in combination with targeted antifungal therapy.
Antifungal Regimen: Mild or localized cases may respond to extended courses of azoles. For deep tissue invasion or aggressive infections, sequential combination therapy using intravenous Amphotericin B and Voriconazole, followed by oral Itraconazole or Posaconazole, has proven highly effective.
Susceptibility: G. klebahnii typically displays low Minimum Inhibitory Concentrations (MICs) to Amphotericin B and advanced azoles (Voriconazole, Itraconazole), but can exhibit variable or poor responses to Fluconazole.
Prevention
Glycemic Control: Maintain strict blood glucose regulations, as undiagnosed or poorly managed diabetes is a primary trigger for invasive presentation.
Wound Care: Thoroughly clean and protect traumatic skin injuries, burns, or surgical wounds to stop accidental environmental inoculation.
Infection Control: Practice stringent hygiene and monitor high-risk, neutropenic hospital patients for breakthrough fungal infections during broad-spectrum antibiotic courses
Introduction Organism: Gram-negative, encapsulated, facultative anaerobic, rod-shaped bacterium. Epidemiology: Major cause of healthcare-associated infections (HAIs)…